Logo image of ALMKS.PA

MAKING SCIENCE GROUP SA (ALMKS.PA) Stock Fundamental Analysis

EPA:ALMKS - ES0105463006 - Common Stock

9.05 EUR
+0.15 (+1.69%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ALMKS scores 3 out of 10 in our fundamental rating. ALMKS was compared to 62 industry peers in the Media industry. ALMKS has a bad profitability rating. Also its financial health evaluation is rather negative. ALMKS is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALMKS has reported negative net income.
ALMKS had a positive operating cash flow in the past year.
ALMKS had negative earnings in 4 of the past 5 years.
ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

ALMKS has a worse Return On Assets (-1.00%) than 64.52% of its industry peers.
Looking at the Return On Equity, with a value of -6.68%, ALMKS is doing worse than 66.13% of the companies in the same industry.
ALMKS's Return On Invested Capital of 7.61% is fine compared to the rest of the industry. ALMKS outperforms 74.19% of its industry peers.
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROIC 7.61%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

ALMKS's Operating Margin of 1.87% is in line compared to the rest of the industry. ALMKS outperforms 40.32% of its industry peers.
ALMKS's Operating Margin has declined in the last couple of years.
The Gross Margin of ALMKS (20.49%) is worse than 83.87% of its industry peers.
ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.49%
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALMKS is still creating some value.
Compared to 1 year ago, ALMKS has more shares outstanding
The number of shares outstanding for ALMKS has been increased compared to 5 years ago.
The debt/assets ratio for ALMKS has been reduced compared to a year ago.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALMKS has an Altman-Z score of 1.74. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
ALMKS has a Altman-Z score of 1.74. This is comparable to the rest of the industry: ALMKS outperforms 59.68% of its industry peers.
The Debt to FCF ratio of ALMKS is 1126.96, which is on the high side as it means it would take ALMKS, 1126.96 years of fcf income to pay off all of its debts.
ALMKS has a Debt to FCF ratio of 1126.96. This is comparable to the rest of the industry: ALMKS outperforms 41.94% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that ALMKS is not too dependend on debt financing.
ALMKS's Debt to Equity ratio of 0.47 is fine compared to the rest of the industry. ALMKS outperforms 62.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Altman-Z 1.74
ROIC/WACC1.1
WACC6.89%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.75 indicates that ALMKS may have some problems paying its short term obligations.
With a Current ratio value of 0.75, ALMKS is not doing good in the industry: 77.42% of the companies in the same industry are doing better.
ALMKS has a Quick Ratio of 0.75. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKS's Quick ratio of 0.73 is on the low side compared to the rest of the industry. ALMKS is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

7

3. Growth

3.1 Past

ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.02%, which is quite impressive.
The Revenue has grown by 16.03% in the past year. This is quite good.
The Revenue has been growing by 51.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%

3.2 Future

Based on estimates for the next years, ALMKS will show a very strong growth in Earnings Per Share. The EPS will grow by 29.70% on average per year.
ALMKS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.10% yearly.
EPS Next Y30.3%
EPS Next 2Y33.71%
EPS Next 3Y29.7%
EPS Next 5YN/A
Revenue Next Year33.94%
Revenue Next 2Y25.99%
Revenue Next 3Y22.1%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 20.63, which indicates a rather expensive current valuation of ALMKS.
The rest of the industry has a similar Price/Forward Earnings ratio as ALMKS.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, ALMKS is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 20.63
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

ALMKS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALMKS is more expensive than 67.74% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALMKS.
Industry RankSector Rank
P/FCF 1618.9
EV/EBITDA 9.64
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMKS's earnings are expected to grow with 29.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.71%
EPS Next 3Y29.7%

0

5. Dividend

5.1 Amount

ALMKS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAKING SCIENCE GROUP SA

EPA:ALMKS (9/5/2025, 7:00:00 PM)

9.05

+0.15 (+1.69%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners3.56%
Inst Owner ChangeN/A
Ins Owners63.56%
Ins Owner ChangeN/A
Market Cap81.27M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-36.76%
EPS NY rev (3m)-36.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.94%
Revenue NY rev (3m)7.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.63
P/S 0.3
P/FCF 1618.9
P/OCF 249.37
P/B 3.16
P/tB N/A
EV/EBITDA 9.64
EPS(TTM)-0.19
EYN/A
EPS(NY)0.44
Fwd EY4.85%
FCF(TTM)0.01
FCFY0.06%
OCF(TTM)0.04
OCFY0.4%
SpS30.46
BVpS2.87
TBVpS-4.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1%
ROE -6.68%
ROCE 10.35%
ROIC 7.61%
ROICexc 13.76%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.49%
FCFM 0.02%
ROA(3y)-2.48%
ROA(5y)-1.44%
ROE(3y)-22.79%
ROE(5y)-9.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.38%
GM growth 5Y-5.28%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1126.96
Debt/EBITDA 1.05
Cap/Depr 4.23%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.8%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.73
Altman-Z 1.74
F-Score6
WACC6.89%
ROIC/WACC1.1
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-319.11%
EPS Next Y30.3%
EPS Next 2Y33.71%
EPS Next 3Y29.7%
EPS Next 5YN/A
Revenue 1Y (TTM)16.03%
Revenue growth 3Y35.32%
Revenue growth 5Y51.21%
Sales Q2Q%21.07%
Revenue Next Year33.94%
Revenue Next 2Y25.99%
Revenue Next 3Y22.1%
Revenue Next 5YN/A
EBIT growth 1Y279.3%
EBIT growth 3YN/A
EBIT growth 5Y41.57%
EBIT Next Year207.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.63%
OCF growth 3Y-64.38%
OCF growth 5YN/A